CN106974923B - Sutherlandin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用 - Google Patents
Sutherlandin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用 Download PDFInfo
- Publication number
- CN106974923B CN106974923B CN201610028174.8A CN201610028174A CN106974923B CN 106974923 B CN106974923 B CN 106974923B CN 201610028174 A CN201610028174 A CN 201610028174A CN 106974923 B CN106974923 B CN 106974923B
- Authority
- CN
- China
- Prior art keywords
- coumarate
- cis
- sutherlandin
- preparation
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010039073 rheumatoid arthritis Diseases 0.000 title claims abstract description 18
- 239000003814 drug Substances 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title abstract description 18
- 150000001875 compounds Chemical class 0.000 claims abstract description 23
- WBCMGDNFDRNGGZ-ACNVUDSMSA-N coumarate Natural products COC(=O)C1=CO[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]3[C@@H]1C=C[C@]34OC(=O)C(=C4)[C@H](C)OC(=O)C=Cc5ccc(O)cc5 WBCMGDNFDRNGGZ-ACNVUDSMSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 241000545405 Tripterygium Species 0.000 abstract description 7
- 229930182470 glycoside Natural products 0.000 abstract description 7
- 150000002338 glycosides Chemical class 0.000 abstract description 7
- 210000002966 serum Anatomy 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 6
- 208000009386 Experimental Arthritis Diseases 0.000 abstract description 3
- 241000160765 Erebia ligea Species 0.000 abstract description 2
- 241001254119 Sorbaria sorbifolia Species 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- 239000002904 solvent Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 9
- 238000001914 filtration Methods 0.000 description 8
- 239000013078 crystal Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 239000002775 capsule Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000005662 Paraffin oil Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000003356 anti-rheumatic effect Effects 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000003929 heteronuclear multiple quantum coherence Methods 0.000 description 2
- 238000002114 high-resolution electrospray ionisation mass spectrometry Methods 0.000 description 2
- 210000000548 hind-foot Anatomy 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 235000021018 plums Nutrition 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 238000001026 1H--1H correlation spectroscopy Methods 0.000 description 1
- XILIYVSXLSWUAI-UHFFFAOYSA-N 2-(diethylamino)ethyl n'-phenylcarbamimidothioate;dihydrobromide Chemical compound Br.Br.CCN(CC)CCSC(N)=NC1=CC=CC=C1 XILIYVSXLSWUAI-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010036030 Polyarthritis Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005100 correlation spectroscopy Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 239000002988 disease modifying antirheumatic drug Substances 0.000 description 1
- 238000002072 distortionless enhancement with polarization transfer spectrum Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- JMANVNJQNLATNU-UHFFFAOYSA-N glycolonitrile Natural products N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 1
- 238000001052 heteronuclear multiple bond coherence spectrum Methods 0.000 description 1
- 238000004896 high resolution mass spectrometry Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 208000030428 polyarticular arthritis Diseases 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610028174.8A CN106974923B (zh) | 2016-01-16 | 2016-01-16 | Sutherlandin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610028174.8A CN106974923B (zh) | 2016-01-16 | 2016-01-16 | Sutherlandin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106974923A CN106974923A (zh) | 2017-07-25 |
CN106974923B true CN106974923B (zh) | 2020-11-03 |
Family
ID=59340262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610028174.8A Active CN106974923B (zh) | 2016-01-16 | 2016-01-16 | Sutherlandin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106974923B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1823870A (zh) * | 2005-12-30 | 2006-08-30 | 南方医科大学 | 一种南蛇藤中成药及其在抗类风湿关节炎中的应用 |
CN101596244A (zh) * | 2009-06-26 | 2009-12-09 | 鲍虎堂 | 一种治疗风湿类风湿性关节炎的外用药 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003257369A1 (en) * | 2002-08-19 | 2004-03-03 | Phamacogenetics Limited | Methods of predicting gabaa receptor efficacies for flavonoid compounds and uses therefor |
MXPA06012966A (es) * | 2006-11-08 | 2009-02-18 | Mexico Quimica Agronomica | Composicion bactericida funguicida para ser utilizada en plantas. |
KR100895110B1 (ko) * | 2007-04-27 | 2009-04-28 | 주식회사 유엔아이 | 천연 산야초 발효 흑마늘, 그 제조방법, 및 그것을포함하는 건강식품 |
CN101773577B (zh) * | 2010-01-29 | 2012-06-27 | 刘志民 | 用于治疗风湿、关节炎、老年性退行性关节病的关东茶浴包 |
CN104758797A (zh) * | 2012-01-05 | 2015-07-08 | 谢有珠 | 芦荟防病治病植物性中草药与皮肤吸收水药和食疗 |
CN103301288B (zh) * | 2013-06-12 | 2014-08-27 | 邬存娟 | 一种治疗痛风性关节炎的中药组合物 |
-
2016
- 2016-01-16 CN CN201610028174.8A patent/CN106974923B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1823870A (zh) * | 2005-12-30 | 2006-08-30 | 南方医科大学 | 一种南蛇藤中成药及其在抗类风湿关节炎中的应用 |
CN101596244A (zh) * | 2009-06-26 | 2009-12-09 | 鲍虎堂 | 一种治疗风湿类风湿性关节炎的外用药 |
Non-Patent Citations (4)
Title |
---|
A new cyanogenic glycoside from sorbaria sorbifolia var. stellipila;Kim DK, et al.;《Chemical & Pharmaceutical Bulletin》;20001130;第48卷(第11期);第1766-1767页 * |
Kim DK, et al..A new cyanogenic glycoside from sorbaria sorbifolia var. stellipila.《Chemical & Pharmaceutical Bulletin》.2000,第48卷(第11期),第1766-1767页. * |
Leucine-derived cyanogenic glucosides in the Rosaceae-Spiraeoideae;Nahrstedt A, et al.;《Phytochemistry》;19811231;第20卷(第6期);第1309-1310页 * |
东北珍珠梅化学成分的研究;李孝栋等;《中国中药杂志》;20021130;第27卷(第11期);第841-843页 * |
Also Published As
Publication number | Publication date |
---|---|
CN106974923A (zh) | 2017-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH01157995A (ja) | 鎮痛−抗炎症活性を有するガングリオシドの内部エステル | |
EP2172206A1 (en) | The method for a sequoyitol-containing extract obtaining from the genus of trifolium, sobyean and ginkgo biloba and use thereof | |
CA2502703C (en) | A natural compound for prevention and treatment of diabetes, process for preparing the same, and pharmaceutical use thereof | |
CN111253247B (zh) | 一种具有抗炎活性的新酚酸类化合物的制备方法及应用 | |
CN101612183B (zh) | 一种乌骨藤皂苷提取物、药物组合物、制备方法及其应用 | |
WO2024031997A1 (zh) | 一种n-n-双-恶唑烷酮生物碱类化合物、制备方法及在医药领域的应用 | |
JP3128823B2 (ja) | 制癌化合物およびその製造法 | |
TWI610676B (zh) | 神經細胞死抑制劑、抗阿茲海默症劑、抗腦機能減退劑、具有抗阿茲海默症作用或抗腦機能減退作用的醫藥品及神經細胞死抑制劑的製造方法 | |
CN106977560B (zh) | 2S-cardiospermin-5-benzoate的制备及其在制备治疗类风湿关节炎药物中的应用 | |
CN106977561B (zh) | Sutherlandin-5-p-hydroxybenzoate的制备及其在制备治疗类风湿关节炎药物中的应用 | |
CN106974923B (zh) | Sutherlandin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用 | |
CN106974922B (zh) | 2S-cardiospermin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用 | |
CN106974924B (zh) | Isocardiospermin-5-p-hydroxybenzoate的制备及其在制备治疗类风湿关节炎药物中的应用 | |
CN106974921B (zh) | 2R-cardiospermin-5-p-hydroxybenzoate的制备及其在制备治疗类风湿关节炎药物中的应用 | |
CN102250197B (zh) | 一种麦冬总甾体皂苷提取物的制备方法及应用 | |
CN112592328B (zh) | 草豆蔻中二芳基庚烷-查尔酮聚合物及其药物组合物与应用 | |
CN110563688B (zh) | 具有抗补体活性的苯并吡喃类化合物及其用途 | |
CN103204860B (zh) | 具有神经保护作用的石蒜科生物碱类化合物 | |
CN101633661B (zh) | 制备斑蝥酸钠的工艺 | |
CN104447649B (zh) | 甲基萘并[1,2-b]呋喃酰胺类化合物及其药学上可接受的盐及其制备方法和应用 | |
CN114409544B (zh) | 具有血管舒张活性的苯丙素及其提取方法和应用 | |
CN110256518B (zh) | 苦瓜中提取的降血糖化合物 | |
CN112500444B (zh) | 一种化合物及其制备方法和应用 | |
CN112168831B (zh) | 一个雷公藤内酯醇衍生物在防治炎症性肠病中的用途 | |
CN108530504B (zh) | 一种化合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of sutherlandin-5-cis-p-coumarate and its application in the preparation of drugs for the treatment of rheumatoid arthritis Effective date of registration: 20211214 Granted publication date: 20201103 Pledgee: Yantai financing guarantee Group Co.,Ltd. Pledgor: BINZHOU MEDICAL University Registration number: Y2021980014859 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20201103 Pledgee: Yantai financing guarantee Group Co.,Ltd. Pledgor: BINZHOU MEDICAL University Registration number: Y2021980014859 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |